Polypeptide Laboratories Inc
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 365 Maple Ave, Torrance, California (CA) 90503-2602, United States (USA)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 1000519239 · DUNS 962386124
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-05-10
- NAIDrug Quality Assurance2021-11-19
- VAIDrug Quality Assurance2017-07-19
- NAIDrug Quality Assurance2015-12-03
- NAIDrug Quality Assurance2013-04-12
- VAIDrug Quality Assurance2012-02-22
- NAIDrug Quality Assurance2011-07-07
- NAIDrug Quality Assurance2010-01-13
- NAIDrug Quality Assurance2009-03-27
Drugs this plant is listed as making
2 distinct drugs across 2 products name this site in their FDA label.
- MotixafortideBioLineRx USA Inc
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.